FLASCO50 – 50% off of the registration fee for members (Offer limited to HCPs)
Updates in Cancer Therapies: An ASCO/ESMO Review has been developed as a CE activity focusing on the highlights of recent developments presented at this year’s two important international congresses delivering a clear and high-quality comprehensive educational program with key opinion leaders in each cancer field. This two-day live in person event will consist of presentations and questions & answer sessions on key topics in cancer care. This event will run October 14 – 15, 2022 at the Hilton Aventura Miami Hotel in Miami, Florida. The activity is designed for medical oncologists, radiation oncologists, surgical oncologists, oncology nurses, advanced registered nurse practitioners, oncology pharmacists, physician assistants or any other healthcare professional involved in cancer care. This CE activity will include discussions on the latest advances in lung cancer, breast cancer, prostate cancer, colorectal cancer and other solid tumors as well as hematological malignancies including chronic lymphocytic leukemia, B-cell and T-cell non-Hodgkin’s lymphoma and multiple myeloma; also a topic on circulating tumor DNA (ctDNA) and how this novel technology will be used in oncology has been included in the 2021 ASCO/ESMO review agenda. The activity has been developed by the educational committee to bring together the many advances in each of these diseases to this dynamic program after a careful review of the evaluations done in previous years based on the opinions of the attendees.
